ArticleScientific reports2017

MicroRNA-26a targets MAPK6 to inhibit smooth muscle cell proliferation and vein graft neointimal hyperplasia.

Juanjuan Tan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.